Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wits Health Consortium (WHC) is a wholly-owned subsidiary of the University of the Witwatersrand, Johannesburg, established to manage the commercial and research activities of the Faculty of Health Sciences. The organization operates as a premier clinical research management entity in Africa, providing essential infrastructure, financial administration, and human resources support for large-scale health projects. WHC hosts several world-renowned research units, including the Wits Reproductive Health and HIV Institute (Wits RHI) and the Vaccines and Infectious Diseases Analytics (VIDA) Research Unit. It plays a pivotal role in global health by conducting Phase 1 through Phase 4 clinical trials for international pharmaceutical companies and donor organizations. WHC is a key partner for major global health stakeholders such as the Bill & Melinda Gates Foundation, the NIH, and USAID, focusing heavily on infectious diseases and maternal health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wits Health Consortium.